JUM Parker Laboratories, Inc
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basseau, F.
Right arrow Articles by Saint-Amon, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basseau, F.
Right arrow Articles by Saint-Amon, A.

Journal of Ultrasound in Medicine, Vol 19, Issue 3 171-176, Copyright © 2000 by American Institute of Ultrasound in Medicine


JOURNAL ARTICLE

Doppler frequency shift and time-domain velocity enhancement induced by an ultrasonographic contrast agent

F. Basseau, N. Grenier, H. Trillaud, C. Douws and A. Saint-Amon
Service de Radiologie B, Groupe Hospitalier Pellegrin, Bordeaux, France.

The aim of this study was to evaluate in rabbit aorta the effect of three bolus doses of Levovist on velocity values measured with spectral Doppler sonography and with time-domain correlation method (color velocity imaging). At each step, a mean peak systolic velocity was calculated from five measurements. These measurements were taken before injection, at 20 s after, at every 30 s till the third minute, and at every minute until return to peak systolic velocity at baseline value. Total duration of enhancement was noted after each injection. After each injection, once the systolic velocity values return to baseline values, a 3 min delay was observed before the following intravenous contrast agent injection was done. With Doppler spectral analysis, after the first injection, peak systolic velocity enhancement was 15 +/- 8.4% (5 to 28%), with a 6.4 +/- 4.3 min duration. After the second injection, peak systolic velocity enhancement was 15.8 +/- 8.4% (5 to 28%) with an 8.8 +/- 4 min duration. After the third injection, it was 14 +/- 9.8% (5 to 34%) with a 13.6 +/- 7.6 min duration (P = 0.04). Peak systolic velocity measured with color velocity imaging remained unchanged after every injection. Doppler velocities were increased by a bolus injection of a contrast agent. Amplitude was not cumulative with the number of injections but was cumulative on its duration. Velocity measurement with time-domain correlation was not influenced by repeated injections.


This article has been cited by other articles:


Home page
Eur Heart J SupplHome page
G. Deklunder
Role of ultrasound and contrast-enhanced ultrasound in patients with cerebrovascular disease
Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C51 - C55.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Institute of Ultrasound in Medicine.